Juliette Berangere Audet SEC EDGAR Filings (CIK 0002000393)

SEC EDGAR filings, ownership reports, and insider transactions for Juliette Berangere Audet.

Business address
C/O Newamsterdam Pharma Company N.V., Gooimeer 2 35, Naarden, Netherlands, 1411 DC
Top holdings (ownership)
NAMS
Get insider transactions for this reporting owner
Juliette Berangere Audet has filed 6 SEC EDGAR filings since 29 Dec 2023

Latest Filings

Recent SEC filings for Juliette Berangere Audet including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 02 May 2025 01 May 2025 001-41562
4 Open 4 document View SEC filing for 4 4 07 Jan 2025 07 Jan 2025 001-41562
4 Open 4 document View SEC filing for 4 4 06 Jan 2025 02 Jan 2025 001-41562
4 Open 4 document View SEC filing for 4 4 30 Sep 2024 26 Sep 2024 001-41562
4 Open 4 document View SEC filing for 4 4 02 Apr 2024 01 Apr 2024 001-41562
3 Open 3 document View SEC filing for 3 3 29 Dec 2023 29 Dec 2023 001-41562

About this filer

Juliette Berangere Audet files with the SEC under CIK 0002000393. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages